Welcome to your source of quality news, articles, analysis and latest data.

Complete information on:

REGENERON PHARMACEUTICALS, INC.

Company data, financial data, shareholder information and contact data
Name:REGENERON PHARMACEUTICALS, INC.
Company number:1226128
Company status:Active
Incorporation date:11 January 1988 (over 33 years ago)
-
Company type:DOMESTIC BUSINESS CORPORATION
Jurisdiction:New York (US)
Business number:unavailable
Registered address:28 LIBERTY STREET, NEW YORK, 10005, NEW YORK, United States
Agent name:unavailable
Identifiers:US Federal CAGE number: 544P9
Previous names:REGENERON PHARMACEUTICALS, INC.
Telephone numbers:["Number: +1 9143457498"]
Websites:["http://www.regeneron.com","http://www.regeneron.com/"]
Company addresses:Company Address 777 OLD SAW MILL RIVER RD, TARRYTOWN, NY, 105916717
Head Office Address REGENERON PHARMACEUTICALS, INC., 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NEW YORK, 10591
Latest events:1988-01-11 - 2019-12-05 Addition of officer C T CORPORATION SYSTEM, dos process agent
1988-01-11 - 2020-01-06 Addition of officer REGENERON PHARMACEUTICALS, INC, dos process agent
2020-01-06 - 2020-04-02 Removal of officer C T CORPORATION SYSTEM, dos process agent
Branches:0 inactive branch REGENERON PHARMACEUTICALS, INC. (Kentucky (US))
0 branch Regeneron Pharmaceuticals, Inc. (Alaska (US), 30 Mar 2015- )
0 branch Regeneron Pharmaceuticals, Inc. (Rhode Island (US), 30 Mar 2015- )
0 branch REGENERON PHARMACEUTICALS, INC. (Arkansas (US), 20 Mar 2015- )
0 branch REGENERON PHARMACEUTICALS, INC. (Utah (US), 24 Aug 2011- )
Subsidiaries:0 OSMR Holdings (Bermuda, 9 Oct 2012- )
0 REGENERON INTERNATIONAL LIMITED (Ireland, 19 Mar 2014- )
0 REGENERON GENETICS CENTER LLC (Delaware (US), 4 Nov 2013- )
0 REGENERON HEALTHCARE SOLUTIONS, INC. (New York (US), 16 Oct 2014- )
0 REGENERON IRELAND HOLDINGS UNLIMITED COMPANY (Ireland, 26 Oct 2012- )
Trademark registrations:1. Mark text
Register United States Patent and Trademark Office
NICE Classifications 5
Registration Date 2021-05-11
Expiry Date
Status label
2. Mark text EVKEEZA
Register United States Patent and Trademark Office
NICE Classifications 5
Registration Date 2021-04-20
Expiry Date
Status label
3. Mark text LIBTAYO
Register United States Patent and Trademark Office
NICE Classifications 5
Registration Date 2020-12-08
Expiry Date
Status label
4. Mark text LIBTAYO
Register United States Patent and Trademark Office
NICE Classifications 5
Registration Date 2020-12-08
Expiry Date
Status label
5. Mark text LOOK TO YOUR FUTURE
Register United States Patent and Trademark Office
NICE Classifications 35, 44
Registration Date 2020-09-15
Expiry Date
Status label
Officers:C T CORPORATION SYSTEM registered agent
LEONARD S. SCHLEIFER chief executive officer
REGENERON PHARMACEUTICALS, INC INC
Officers:
Name:

C T CORPORATION SYSTEM, Position: registered agent

Name:

LEONARD S. SCHLEIFER, Position: chief executive officer

Name:

REGENERON PHARMACEUTICALS, INC, Position: INC

Data from other sources:
Regeneron Pharmaceuticals Inc, US133444607
From: US, NY, Tarrytown
Contact: www.regeneron.com, , +1 9148477000

Status:
BNP PARIBAS ARBITRAGE Shareholder of Regeneron Pharmaceuticals Inc
TWO SIGMA ADVISERS, LP via its funds Shareholder of Regeneron Pharmaceuticals Inc
TWO SIGMA ADVISERS, LP via its funds Shareholder of Regeneron Pharmaceuticals Inc
SANOFI Shareholder of Regeneron Pharmaceuticals Inc
SCHLEIFER LEONARD S. FAMILY Shareholder of Regeneron Pharmaceuticals Inc
CRESTVIEW LLC via its funds Shareholder of Regeneron Pharmaceuticals Inc
CRESTVIEW LLC via its funds Shareholder of Regeneron Pharmaceuticals Inc
WELLINGTON MANAGEMENT GROUP LLP via its funds Shareholder of Regeneron Pharmaceuticals Inc
WELLINGTON MANAGEMENT GROUP LLP via its funds Shareholder of Regeneron Pharmaceuticals Inc
PIEDMONT INVESTMENT ADVISORS LLC Shareholder of Regeneron Pharmaceuticals Inc
PIEDMONT INVESTMENT ADVISORS LLC Shareholder of Regeneron Pharmaceuticals Inc
BANK OF NEW YORK MELLON CORPORATION via its funds Shareholder of Regeneron Pharmaceuticals Inc
BANK OF NEW YORK MELLON CORPORATION via its funds Shareholder of Regeneron Pharmaceuticals Inc
REGERINGSKANSLIET via its funds Shareholder of Regeneron Pharmaceuticals Inc
MR ERIC SHOOTER Shareholder of Regeneron Pharmaceuticals Inc
BIOTECH GROWTH TRUST PLC (THE) Shareholder of Regeneron Pharmaceuticals Inc
BIOTECH GROWTH TRUST PLC (THE) Shareholder of Regeneron Pharmaceuticals Inc
ORBIMED ADVISORS LLC via its funds Shareholder of Regeneron Pharmaceuticals Inc
ORBIMED ADVISORS LLC via its funds Shareholder of Regeneron Pharmaceuticals Inc
POINT72 CAPITAL HOLDINGS LP via its funds Shareholder of Regeneron Pharmaceuticals Inc
POINT72 CAPITAL HOLDINGS LP via its funds Shareholder of Regeneron Pharmaceuticals Inc
NEW YORK LIFE INSURANCE CO. via its funds Shareholder of Regeneron Pharmaceuticals Inc
NEW YORK LIFE INSURANCE CO. via its funds Shareholder of Regeneron Pharmaceuticals Inc
INVESCO LTD via its funds Shareholder of Regeneron Pharmaceuticals Inc
T. ROWE PRICE GROUP, INC via its funds Shareholder of Regeneron Pharmaceuticals Inc
T. ROWE PRICE GROUP, INC via its funds Shareholder of Regeneron Pharmaceuticals Inc
RUSSELL INVESTMENT MANAGEMENT LLC via its funds Shareholder of Regeneron Pharmaceuticals Inc
RUSSELL INVESTMENT MANAGEMENT LLC via its funds Shareholder of Regeneron Pharmaceuticals Inc
FMR LLC via its funds Shareholder of Regeneron Pharmaceuticals Inc
FMR LLC via its funds Shareholder of Regeneron Pharmaceuticals Inc
DE SHAW GROUP via its funds Shareholder of Regeneron Pharmaceuticals Inc
DE SHAW GROUP via its funds Shareholder of Regeneron Pharmaceuticals Inc
FRANKLIN RESOURCES, INC. via its funds Shareholder of Regeneron Pharmaceuticals Inc
FRANKLIN RESOURCES, INC. via its funds Shareholder of Regeneron Pharmaceuticals Inc
MW GROUP LP via its funds Shareholder of Regeneron Pharmaceuticals Inc
MW GROUP LP via its funds Shareholder of Regeneron Pharmaceuticals Inc
UBS GROUP AG via its funds Shareholder of Regeneron Pharmaceuticals Inc
UBS GROUP AG via its funds Shareholder of Regeneron Pharmaceuticals Inc
Other companies:
All information found on this page is extracted from public sources and should not be used in any official way.